Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19

NCT04545008 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study was stopped due to poor accrual.

Conditions

Covid19

Interventions

DRUG: Famotidine
DRUG: N-Acetyl cysteine

Sponsor

Prisma Health-Upstate

Collaborators

[object Object]